在MDM2-放大性脂肉瘤中,使用甲状腺活动和任何分离组件的大小进行风险评估

Hao Wu1, Madina Sukhanova2, Haiming Tang1

  • 1From the Departments of Pathology (Wu, Tang, Laskin), Smilow Cancer Center, and Medicine (Deshpande), Yale School of Medicine and Yale New Haven Hospital, New Haven, Connecticut.

概括

脂肪肉瘤中非分化成分的大小,而不是整体瘤大小,可以预测患者的结果. 较大的脱差区域和较高的线粒细胞计数与MDM2-放大型脂类瘤中不良事件相关.